In MM, HMGB1 has been shown to induce chemoresistance through the nuclear factor-κB pathway, evidenced by the increased sensitivity to chemotherapy and induction of DNA damage and cellular apoptosis upon downregulation of HMGB1 [12,13]. The gene discussed is HMGB1; the disease is Miyoshi myopathy.